ANI Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €956.94M +4.9% €196.66M +10.2% 20.6% +0.0098 pp N/A N/A
    (estimated) €911.93M +5.8% €178.44M +7.2% 19.6% +0.0024 pp N/A N/A
    (estimated) €861.64M +9.6% €166.51M +17.2% 19.3% +0.013 pp €185.94M +33.1% 21.6% +0.038 pp
    (estimated) €786.44M +9.5% €142.09M +12.8% 18.1% +0.0054 pp €139.70M +2.4% 17.8% -0.012 pp
    (estimated) €718.53M +37.1% €125.97M -897.4% 17.5% +0.21 pp €136.41M +97.5% 19.0% +0.058 pp
    €524.03M +26.2% -€15.80M -198.6% -3.0% -0.069 pp €69.06M -41.1% 13.2% -0.15 pp
    €415.23M +53.9% €16.02M -139.2% 3.9% +0.19 pp €117.26M -1,032.1% 28.2% +0.33 pp
    €269.86M +46.4% -€40.85M +12.4% -15.1% +0.046 pp -€12.58M -154.7% -4.7% -0.17 pp
    €184.35M +3.7% -€36.34M +88.9% -19.7% -0.089 pp €23.00M -67.7% 12.5% -0.28 pp
    €177.82M +0.9% -€19.23M -470.0% -10.8% -0.14 pp €71.30M +14.2% 40.1% +0.047 pp
    €176.17M +2.5% €5.20M -60.7% 3.0% -0.047 pp €62.42M -6.2% 35.4% -0.033 pp
    €171.93M +14.0% €13.22M -1,540.0% 7.7% +0.083 pp €66.52M -47.1% 38.7% -0.45 pp
    €150.84M +37.5% -€917.78K -127.4% -0.6% -0.037 pp €125.74M -16.5% 83.4% -0.54 pp
    €109.71M +68.5% €3.36M -74.4% 3.1% -0.17 pp €150.57M +253.4% 137.2% +0.72 pp
    €65.10M +36.4% €13.11M -46.5% 20.1% -0.31 pp €42.60M -13.6% 65.4% -0.38 pp
    €47.74M +86.1% €24.52M +9,450.5% 51.4% +0.50 pp €49.29M -1,191.8% 103.2% +1.2 pp
    €25.66M +1,207.5% €256.74K -101.1% 1.0% +12 pp -€4.51M -78.5% -17.6% +11 pp
    €1.96M +428.7% -€23.64M -46.3% -1,204.7% +110 pp -€21.04M -47.7% -1,072.3% +98 pp
    €371.17K -82.4% -€44.02M +11.7% -11,859.7% -100 pp -€40.22M +17.8% -10,835.1% -92 pp
    €2.11M +96.7% -€39.40M -2.8% -1,867.1% +19 pp -€34.15M +119.2% -1,618.0% -1.7 pp
    €1.07M -66.7% -€40.54M +172.8% -3,777.9% -33 pp -€15.58M +22.7% -1,451.9% -11 pp
    €3.22M +666.8% -€14.86M +129.7% -460.9% +11 pp -€12.70M -2,034.6% -393.7% -5.5 pp
    €420.55K -96.6% -€6.47M -371.7% -1,538.3% -16 pp €656.28K -115.5% 156.1% +1.9 pp
    €12.32M +5,488.8% €2.38M -128.9% 19.3% +38 pp -€4.23M -39.8% -34.3% +32 pp
    €220.36K +231.7% -€8.23M -19.7% -3,735.6% +120 pp -€7.02M -20.4% -3,185.6% +100 pp
    €66.43K +18.9% -€10.25M +101.6% -15,427.9% -63 pp -€8.82M +87.5% -13,274.8% -49 pp
    €55.86K -97.7% -€5.08M +56.4% -9,099.1% -90 pp -€4.70M +40.5% -8,417.8% -83 pp
    €2.42M +62.2% -€3.25M +45.9% -134.5% +0.15 pp -€3.35M +125.9% -138.5% -0.39 pp
    €1.49M +∞% -€2.23M -24.0% -149.4% -1.5 pp -€1.48M -45.1% -99.4% -0.99 pp
    €0.00 +NaN% -€2.93M +144.4% N/A -€2.70M +77.4% N/A
    €0.00 -100.0% -€1.20M -47.1% N/A -€1.52M -38.8% N/A
    €104.97K -€2.27M -2,161.1% -€2.49M -2,369.9%

    Notifications